Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
AHCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.72 - $11.90
Previous CloseN/A
Volume245.49K
Average Volume (3M)1.72M
Market Cap
$1.05B
Enterprise Value$3.33B
Total Cash (Recent Filing)$1.07M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)12.9
Beta0.91
Next Earnings
May 13, 2025EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.60
Shares Outstanding134,867,000
10 Day Avg. Volume1,649,715
30 Day Avg. Volume1,722,221
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.41
Price to Cash Flow (P/CF)2.20
P/FCF Ratio1.80
Enterprise Value/Market Cap3.17
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.89
Enterprise Value/Ebitda5.83
Forecast
1Y Price Target
$13.86Price Target Upside89.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
AdaptHealth News
PremiumCompany Announcements
AdaptHealth Exceeds Guidance Amid Challenges in Earnings Call
PremiumCompany Announcements
AdaptHealth Corp. Reports 2024 Financial Results and 2025 Outlook
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAHCO had a very strong 4Q with a revenue beat and a significant EBITDA beat.
Operational ChangesNew leadership, focus, and accountability appears to be taking shape.
Sleep And Respiratory SegmentSleep continues to be very strong with new starts up significantly and resupply census up compared to the prior year.
Bears Say
2024 Outlook3Q results were largely disappointing, with diabetes still lagging and the 2024 outlook lowered.
Diabetes RevenueDiabetes revenue declined 7.3% in 4Q and 6.9% for the year.
Diabetes SegmentAHCO has really struggled to manage its diabetes franchise, and another cut to numbers doesn't increase confidence.
---
Ownership Overview
3.49% Insiders
21.95% Mutual Funds
6.06% Other Institutional Investors
46.70% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $7.72 and its highest was $11.90 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $1.05B.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is May 13, 2025 which is in 21 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on Feb 25, 2025. The company reported $0.427 earnings per share for the quarter, beating the consensus estimate of $0.282 by $0.145.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is 0.05.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 134,867,000 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.427 in its last earnings report, beating expectations of $0.282. Following the earnings report the stock price went up 24.444%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
---
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.86 (89.09% Upside)
$13.86 (89.09% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 228.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $327.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.52%
12-Months-Change
Fundamentals
Return on Equity
5.45%
Trailing 12-Months
Asset Growth
-0.91%
Trailing 12-Months
Company Description
AdaptHealth
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
---
AHCO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
AdaptHealth demonstrated notable achievements by exceeding financial guidance and reducing debt significantly, while also extending a major capitated contract with Humana. However, challenges remain with the Diabetes Health segment continuing to decline and flat overall revenue growth. The outlook for 2025 includes potential negative growth, though efforts to improve segments and operational performance are underway.Read More>---
AHCO Stock 12 Month Forecast
Average Price Target
$13.86
▲(89.09% Upside)
Technical Analysis
Best Analysts Covering AHCO
1 Year
1 Year Success Rate
7/32 ratings generated profit
1 Year Average Return
-14.07%
reiterated a buy rating 2 months ago
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 21.88% of your transactions generating a profit, with an average return of -14.07% per trade.
---